Cite
HARVARD Citation
Graf, L. et al. (2021). A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A. Journal of medical economics. pp. 1493-1498. [Online].